Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 5Phase 4 3Phase 2 2Phase 1 2Phase 1/2 1

Status

Completed 11Unknown 4Terminated 2Active not recruiting 2Withdrawn 1Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 285Prostatic Neoplasms 208Neoplasms 202Neoplasm Metastasis 179Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 157Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 104Carcinoma, Renal Cell 104Brain Neoplasms 89Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 84Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 59

Interventions

incobotulinumtoxinA 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Cancer Pain × Clear all
NCT01931865 2015-12-31

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Yale University

Phase 2 Terminated
12 enrolled 6 charts

Cancer Pain, Pain

NCT00684242 2013-01-28

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡